Page Arthur B Holds Position in Eog Resources (EOG); Bristol Myers Squibb Co (BMY) Stock Rose While Sabby Management Cut by $3.12 Million Its Stake

April 21, 2018 - By Michael Collier

EOG Resources, Inc. (NYSE:EOG) Logo

Page Arthur B increased its stake in Eog Resources (EOG) by 125.54% based on its latest 2017Q4 regulatory filing with the SEC. Page Arthur B bought 4,871 shares as the company’s stock declined 0.73% with the market. The institutional investor held 8,751 shares of the energy company at the end of 2017Q4, valued at $945,000, up from 3,880 at the end of the previous reported quarter. Page Arthur B who had been investing in Eog Resources for a number of months, seems to be bullish on the $65.95 billion market cap company. The stock decreased 0.06% or $0.07 during the last trading session, reaching $113.97. About 3.11M shares traded. EOG Resources, Inc. (NYSE:EOG) has risen 13.87% since April 21, 2017 and is uptrending. It has outperformed by 2.32% the S&P500.

Hal Mintz decreased its stake in Bristol Myers Squibb Co (BMY) by 5.2% based on its latest 2017Q4 regulatory filing with the SEC. Sabby Management Llc sold 51,148 shares as the company’s stock rose 2.38% while stock markets declined. The hedge fund run by Hal Mintz held 931,807 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $57.10M, down from 982,955 at the end of the previous reported quarter. Sabby Management Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $83.66B market cap company. The stock decreased 0.85% or $0.44 during the last trading session, reaching $51.17. About 11.67 million shares traded or 31.31% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 21, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Since January 10, 2018, it had 0 buys, and 3 sales for $6.91 million activity. On Friday, January 12 Trice David W sold $646,120 worth of EOG Resources, Inc. (NYSE:EOG) or 5,570 shares. Donaldson Michael P sold $1.75M worth of EOG Resources, Inc. (NYSE:EOG) on Thursday, January 11.

Among 39 analysts covering EOG Resources (NYSE:EOG), 29 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. EOG Resources had 130 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Tuesday, June 13. The firm has “Hold” rating by RBC Capital Markets given on Monday, November 6. The company was upgraded on Wednesday, January 4 by Bank of America. The rating was maintained by Barclays Capital with “Overweight” on Thursday, September 1. JP Morgan maintained EOG Resources, Inc. (NYSE:EOG) rating on Thursday, October 12. JP Morgan has “Neutral” rating and $96 target. Cowen & Co initiated the stock with “Market Perform” rating in Wednesday, March 30 report. Citigroup maintained the stock with “Buy” rating in Friday, August 5 report. Citigroup downgraded EOG Resources, Inc. (NYSE:EOG) on Friday, July 21 to “Neutral” rating. Robert W. Baird maintained EOG Resources, Inc. (NYSE:EOG) on Friday, January 5 with “Buy” rating. Morgan Stanley maintained EOG Resources, Inc. (NYSE:EOG) on Wednesday, October 18 with “Overweight” rating.

Investors sentiment increased to 0.97 in 2017 Q4. Its up 0.15, from 0.82 in 2017Q3. It is positive, as 48 investors sold EOG shares while 332 reduced holdings. 112 funds opened positions while 257 raised stakes. 477.30 million shares or 0.36% less from 479.04 million shares in 2017Q3 were reported. Salem has invested 0.41% in EOG Resources, Inc. (NYSE:EOG). 23,322 were accumulated by D L Carlson Inv. American Natl Registered Inv Advisor Inc accumulated 7,615 shares. Prudential Pcl accumulated 3,301 shares. Fmr Ltd Liability Company stated it has 20.69 million shares. Employees Retirement Systems Of Texas owns 197,000 shares. Guyasuta Inv Advsr reported 0.02% of its portfolio in EOG Resources, Inc. (NYSE:EOG). Lazard Asset Mngmt Lc has invested 0.6% in EOG Resources, Inc. (NYSE:EOG). Interocean Cap Lc reported 2,105 shares stake. Northwestern Mutual Wealth Management holds 0.01% or 8,643 shares in its portfolio. Synovus Financial reported 0.08% of its portfolio in EOG Resources, Inc. (NYSE:EOG). Winslow Asset Mngmt, Ohio-based fund reported 75,237 shares. Jacobs Levy Equity accumulated 247,952 shares. Sandy Spring State Bank invested in 0.07% or 6,687 shares. Livforsakringsbolaget Skandia Omsesidigt has invested 0.09% of its portfolio in EOG Resources, Inc. (NYSE:EOG).

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It fall, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Zurcher Kantonalbank (Zurich Cantonalbank) owns 363,564 shares for 0.2% of their portfolio. Ls holds 0.34% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 94,246 shares. 3,084 were reported by Perkins Coie Trust. Tiverton Asset Mngmt Llc reported 0.1% in Bristol-Myers Squibb Company (NYSE:BMY). Ckw Group Inc, Hawaii-based fund reported 1,400 shares. D E Shaw And invested in 0.39% or 4.57 million shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh invested in 0.4% or 168,221 shares. Bridges Investment Management reported 20,114 shares stake. Tradewinds Cap Llc has 0.09% invested in Bristol-Myers Squibb Company (NYSE:BMY). Archford Capital Strategies Ltd Liability Corporation has 20,567 shares. Sumitomo Mitsui Tru Hldg holds 0.38% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 4.79M shares. Neumann Mngmt Ltd Liability Corporation stated it has 10,539 shares or 0.4% of all its holdings. Venbio Select Advisor Limited Liability Corporation owns 456,223 shares. Maple Capital Mngmt Inc has invested 0.11% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Willis Inv Counsel reported 0.76% stake.

Sabby Management Llc, which manages about $835.79 million and $1.10B US Long portfolio, upped its stake in Amag Pharmaceuticals Inc (Call) by 299 shares to 553 shares, valued at $733,000 in 2017Q4, according to the filing. It also increased its holding in Astrazeneca Plc (Put) by 5,468 shares in the quarter, for a total of 7,511 shares, and has risen its stake in Sangamo Therapeutics Inc (Put).

Since December 12, 2017, it had 1 insider buy, and 1 insider sale for $85,985 activity. $335,172 worth of stock was sold by Lynch Thomas J. Jr. on Tuesday, December 12.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 12 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 84 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Sell” rating by Societe Generale on Wednesday, April 6. The firm has “Underperform” rating given on Tuesday, February 6 by BMO Capital Markets. On Friday, December 18 the stock rating was initiated by Atlantic Securities with “Underweight”. Citigroup maintained it with “Buy” rating and $72.0 target in Wednesday, October 25 report. Citigroup maintained it with “Buy” rating and $72 target in Wednesday, October 18 report. The rating was maintained by BMO Capital Markets on Wednesday, April 18 with “Underperform”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Piper Jaffray on Friday, September 22. As per Friday, April 29, the company rating was maintained by UBS. BMO Capital Markets maintained the stock with “Sell” rating in Wednesday, August 16 report. On Monday, December 19 the stock rating was upgraded by Jefferies to “Buy”.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26 before the open. They expect $0.84 earnings per share, 0.00% or $0.00 from last year’s $0.84 per share. BMY’s profit will be $1.37 billion for 15.23 P/E if the $0.84 EPS becomes a reality. After $0.68 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 23.53% EPS growth.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts